Results 11 to 20 of about 2,003,708 (339)

Role of Expression of p63 and Calponin in Prostatic Biopsies [PDF]

National Journal of Laboratory Medicine, 2019
Introduction: Histopathological diagnosis of benign prostatic hyperplasia and prostatic carcinoma may pose problems due to presence of mimickers. p63 is confined to basal cells/ myoepithelial cells of prostate and is absent in prostatic cancer.
S Premalatha, S Sreela, Ravi Sivaraman
doaj   +1 more source

Expression of nuclear Ki-67 antigen in prostatic high grade intraepithelial neoplasia and prostatic carcinoma [PDF]

Vojnosanitetski Pregled, 2007
Background/Aim. Prostatic intraepithelial high grade neoplasia (PINHG) is accepted as preneoplastic lesion in prostatic carcinoma. One of the fundamental events in early oncogenesis is the disruption of proliferative activity.
Janković-Veličković Ljubinka, Đorđević Biljana, Rančić Gorana, Marjanović Goran   +3 more
doaj   +1 more source

Supersensitive PSA-Monitored neoadjuvant hormone treatment of clinically localized prostate cancer: Effects on positive margins, tumor detection and epithelial cells in bone marrow [PDF]

, 1998
Objective: The present study was done to investigate the effects of supersensitive PSA-controlled inductive treatment on positive margins, detection of tumor and epithelial cells in bone marrow of 101 patients with untreated and clinically localized ...
J. Kö, J. Spitz, K. Pantel, M. Kossiwakis, M.W. Kö, Th. Enzmann, U. Feek, U. Kaulfuss, W. Martell   +8 more
core   +1 more source

Collision tumor of kidney: A case of renal cell carcinoma with metastases of prostatic adenocarcinoma

Indian Journal of Medical and Paediatric Oncology, 2013
Simultaneous occurrence of prostatic adenocarcinoma and renal cell carcinoma is well documented in the literature. However, metastatic prostatic adenocarcinoma in a kidney harboring a renal cell carcinoma (RCC) is quite rare.
Monika Vyas, Santosh Menon, Sangeeta B Desai   +2 more
doaj   +1 more source

Influence of gross specimen sampling on the incidence of incidental prostatic carcinoma in cystoprostatectomy specimens of patients with bladder carcinoma

Polish Journal of Pathology, 2016
Reported prostate cancer incidence rates vary greatly among cystoprostatectomy samples. We investigated how the thoroughness of prostate sampling influences prostatic carcinoma incidence in bladder cancer patients.
Jernej Mlakar, Metka Volavšek
doaj   +1 more source

Studies on the clinical significance of nonesterified and total cholesterol in urine [PDF]

, 1981
Gas-liquid chromatographic determinations of nonesterified and total urinary cholesterol were performed in 137 normals, 264 patients with various internal diseases without evidence of neoplasias or diseases of the kidney or urinary tract, 497 patients ...
A. Pickel, A. Stadler, BA Vela, D Jüngst, D Jüngst, D. Jüngst, DE Comings, E Bloch, F. J. Marsx, H Sobotka, H Sobotka, H. J. Karl, HF Acevedo, HF Acevedo, HF Acevedo, HF Acevedo, HF Acevedo, HF Acevedo, J Bing, J Frick, J. Wallner, JA Belis, JC Sutherland, JG Zimmer, JW Eagen, M Bruger, M Bruger, M Spiteller-Friedmann, MM Burchell, MM Burchell, P Kerkhoven, S Klahr, SG Mendoza de, TM Chu, W Trappe, W. Eiermann   +35 more
core   +2 more sources

A Review Leveraging a Rare and Unusual Case of Basal Cell Carcinoma of the Prostate

Case Reports in Pathology, 2021
Basal cell carcinoma (BCC) is a rare nonacinar variant of prostatic carcinoma. In spite of prostatic acinar adenocarcinoma being one of the most common carcinomas in prostate,
Lin He, Christopher Metter, Vitaly Margulis, Payal Kapur   +3 more
doaj   +1 more source

Extensive metastases in prostatic carcinoma with normal prostate-specific antigen and raised carcinoembryonic antigen – Small cell carcinoma of prostate: A rare entity

Indian Journal of Medical and Paediatric Oncology, 2018
Small cell carcinoma of prostate is a neuroendocrine tumor of prostate seen in 0.5%–2% of men with carcinoma prostate. Prostate-specific antigen (PSA) is a common tumor marker which is often raised in prostatic carcinoma. However, prostatic carcinoma can
Sanjay Mhalasakant Khaladkar, Kunaal Mahesh Jain, Arijit Ghosh, Rajesh Kuber   +3 more
doaj   +1 more source

Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone agonist and radiotherapy treatment

The Pan African Medical Journal, 2019
Squamous cell carcinoma of the prostate is rare and represents 0.5% to 1% of prostatic carcinomas. Transformation of prostatic adenocarcinoma into squamous cell carcinoma after LH-RH agonist intake has been reported in only 8 cases in the literature.
Hamza Ichaoui, Sonia Ben Nasr, Faten Gargouri, Aref Zribi, Amine Hermi, Sana Fendri, Mehdi Balti, Jihen Ayari, Ramzi Khiari, Issam Msakni, Nada Mansouri, Samir Ghozzi, Abderrazek Haddaoui   +12 more
doaj   +1 more source

Cytoplasmic PTEN Protein Loss Distinguishes Intraductal Carcinoma of the Prostate from High Grade Prostatic Intraepithelial Neoplasia

Modern Pathology, 2012
Intraductal carcinoma of the prostate is a marker of aggressive disease. However, intraductal carcinoma exists on a morphologic continuum with high-grade prostatic intraepithelial neoplasia (PIN) and distinguishing intraductal carcinoma from PIN is a ...
T. Lotan, B. Gumuskaya, Hameed A Rahimi, J. Hicks, T. Iwata, B. Robinson, J. Epstein, A. D. De Marzo   +7 more
semanticscholar   +1 more source